...
首页> 外文期刊>Journal of Infectious Diseases >Influenza B Virus With Modified Hemagglutinin Cleavage Site as a Novel Attenuated Live Vaccine
【24h】

Influenza B Virus With Modified Hemagglutinin Cleavage Site as a Novel Attenuated Live Vaccine

机译:具有改良的血凝素切割位点的乙型流感病毒作为新型减毒活疫苗

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background. Both pandemic and interpandemic influenza is associated with high morbidity and mortality worldwide. Seasonal epidemics are caused by both influenza A and B virus strains that cocirculate with varying predominance and may give rise to severe illness equally. According to World Health Organization recommendations, current annual vaccines are composed of 2 type A and 1 type B virus-specific component.
机译:背景。大流行性流感和大流行间流感都与全世界的高发病率和高死亡率有关。季节性流行病是由甲型和乙型流感病毒以不同的流行率共同流行引起的,并可能同样导致严重的疾病。根据世界卫生组织的建议,当前的年度疫苗由2种A型和1种B型病毒特异性成分组成。

著录项

  • 来源
    《Journal of Infectious Diseases》 |2011年第10期|p.1483-1490|共8页
  • 作者单位

    Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Greifswald, Insel Riems;

    Institut für Labormedizin und Pathobiochemie–Molekulare Diagnostik, Medizinische Fakultät, Biomedizinisches Forschungszentrum;

    Institut für Virologie, Fachbereich Medizin, Philipps-Universität Marburg;

    Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Greifswald, Insel Riems;

    Division of Influenza/Respiratory Viruses, Robert Koch-Institut, Berlin, Germany;

    Division of Influenza/Respiratory Viruses, Robert Koch-Institut, Berlin, Germany;

    Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Greifswald, Insel Riems;

  • 收录信息
  • 原文格式 PDF
  • 正文语种
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号